Previous close | 97.21 |
Open | 96.95 |
Bid | 97.13 x 200 |
Ask | 97.24 x 200 |
Day's range | 95.40 - 98.17 |
52-week range | 36.90 - 98.82 |
Volume | |
Avg. volume | 1,369,255 |
Market cap | 11.876B |
Beta (5Y monthly) | 1.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On April 29, 2024, Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), sold 1,238 shares of the company.
On April 29, 2024, Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), sold 4,084 shares of the company.
Natera Inc (NASDAQ:NTRA), a leader in personalized genetic testing and diagnostics, has seen a recent insider transaction according to the latest SEC Filing.